Document Detail

Herpesvirus saimiri-based endothelin-converting enzyme-1 shRNA expression decreases prostate cancer cell invasion and migration.
MedLine Citation:
PMID:  20949559     Owner:  NLM     Status:  In-Data-Review    
The zinc metalloprotease, endothelin-converting enzyme-1 (ECE-1), which converts the mitogenic peptide endothelin-1 (ET-1) from its biologically inactive precursor big-ET-1, is commonly upregulated in prostate cancer (PC) cells. Consequently, we have sought to suppress ECE-1 expression by using RNAi as a potentially novel therapeutic approach. Therefore, a synthetic 64-nt short-hairpin RNA (shRNA), designed to target the ECE-1 gene, was expressed in an Herpesvirus saimiri (HVS)-based delivery vector. ECE-1 expression in cells transduced with the vector was examined by real-time PCR and Western blotting. The effects of ECE-1 knockdown on PC cell migration and invasion were studied using a scratch assay and Matrigel invasion. These studies, in vitro and ex vivo, demonstrated that the HVS-shRNA viruses could infect and silence ECE-1 expression effectively in human PC cells. Furthermore, it was observed that ECE-1 knockdown in either stromal cells or epithelial cells could significantly reduce invasion of PC-3 cells in coculture by 33 and 31%, respectively. In addition, suppressed migration was also observed in HVS-ECE-1 shRNA-infected PC-3 cells compared to uninfected and HVS-GFP-infected control cell cultures. These findings highlight the potential tumor-suppressing effect of ECE-1 knockdown in cancer cells and novel strategies for future therapeutic developments in advanced PC.
Yue Hong; Stuart Macnab; Louise A Lambert; Anthony J Turner; Adrian Whitehouse; Badar A Usmani
Related Documents :
10419589 - Oestrogen receptor expression in the normal and pre-cancerous breast.
20197399 - Anacardic acid inhibits estrogen receptor alpha-dna binding and reduces target gene tra...
10536189 - Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1.
3664479 - Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating ...
12234989 - The human immunodeficiency virus (hiv)-1 protease inhibitor saquinavir inhibits proteas...
7792809 - Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell...
21194729 - Cd1a immunopositivity in perivascular epithelioid cell neoplasms: true expression or te...
18565219 - Altered localisation of the copper efflux transporters atp7a and atp7b associated with ...
11693299 - Early nephron formation in the developing mouse kidney.
Publication Detail:
Type:  Journal Article     Date:  2010-12-02
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  129     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-05-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  586-98     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 UICC.
Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha...
Next Document:  Endometriosis as a prognostic factor for cancer survival.